StockCharts TV on $TWST (Oct 30, 2026)
TWST reported Thursday and is advancing new-drug development, including the AI-based Twist Rapid Screen, but the stock fell 12% today and is settling at its 10-day simple moving average; RSI/MACD were somewhat positive yet the sharp decline was notable.
Jump to any passage
First, we will take a look at (TWST). This is Twist, a major biotechnology company, which announced its figures on Thursday. The company is certainly seeing a rise and faster movement with regard to the development of new drugs.
The company has also launched what it calls the "Twist Rapid Screen," which is the development of a screening test that also relies on artificial intelligence and allows for a faster screening for the potential presence of new drugs.
So, we had that good progress. However , the stock fell by 12% today. So, we are now settling at the 10-day simple moving average . The RSI and MACD indicators were somewhat positive, but today's sharp decline was noticeable.